Remove tag keytruda
article thumbnail

Merck and Eisai's Keytruda-Lenvima combo chalks up 2 more losses, this time in non-small cell lung cancer

Fierce Pharma

Merck and Eisai’s Keytruda-Lenvima tag team can’t seem to catch a break. Merck and Eisai’s Keytruda-Lenvima tag team can’t seem to catch a break.

336
336
article thumbnail

Risk-sharing agreements are growing at a rate of 24%

Pharmaceutical Technology

This is not the first treatment to come with a high price tag. s Keytruda (pembrolizumab) and Bristol Myers Squibb’s Opdivo (nivolumab), based on the high volume of RSAs arranged for these drugs. million, according to GlobalData’s Price Intelligence (POLI), making it the most expensive drug in the world.

Marketing 105
article thumbnail

Risk sharing agreements soar as market access risk increases

Pharmaceutical Technology

She points out Merck’s Keytruda (pembrolizumab) and Bristol Myers Squibb’s Opdivo (nivolumab) as examples. In some cases, she said, “[drug] innovation would have been otherwise hindered by their price tag alone”.

Marketing 102